human embryonic stem cell derived retinal pigmented epithelial cells
Cell therapyexperimental
Clinical trial activity
5 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2015 (NCT01691261)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- RetinaTissue restoration
tissue restoration - retina
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- embryonic stem cell-derived retinal pigment epithelial cells
- human embryonic stem cell derived retinal pigmented epithelial
- human embryonic stem cell derived retinal pigmented epithelial cells
- human embryonic stem cell derived retinal pigmented epithelial cells
- human embryonic stem cell derived retinal pigment epithelium (rpe) living tissue equivalent
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03963154 | Phase 1/Phase 2 (Phase 2) | Jul 15, 2019 | Centre d'Etude des Cellules Souches |
| NCT03944239 | Phase 1 | Jun 30, 2019 | Capital Medical University, Chinese Academy of Medical Sciences |
| NCT03167203 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2017 | Astellas |
| NCT03305029 | Phase 1 | May 31, 2016 | Cha Medical University |
| NCT01691261 | Phase 1 | Jun 1, 2015 | Pfizer, University of London |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Astellas | For profit | 1 | 1 | 1 | 2017 |
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Centre d'Etude des Cellules Souches | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Cha Medical University | Academic/Hospital | 1 | 1 | 1 | 2016 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Pfizer | For profit | 1 | 1 | 1 | 2015 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2015 |
7 organizations
Page 1 / 1